Hepatic arterial embolization for unresectable hepatocellular carcinomas: do technical factors affect prognosis?-Reference-Cited by-同舟云学术

Hepatic arterial embolization for unresectable hepatocellular carcinomas: do technical factors affect prognosis?

Published:2012-05-30 Issue:7 Volume:30 Page:560-566
ISSN:1867-1071
Container-title:Japanese Journal of Radiology
language:en
Short-container-title:Jpn J Radiol

Author:

Yamakado Koichiro,Miyayama Shiro,Hirota Shozo,Mizunuma Kimiyoshi,Nakamura Kenji,Inaba Yoshitaka,Maeda Akihiro,Matsuo Kunihiro,Nishida Norifumi,Aramaki Takeshi,Anai Hiroshi,Koura Shinichi,Oikawa Shigeo,Watanabe Ken,Yasumoto Taku,Furuichi Kinya,Yamaguchi Masato

Publisher

Springer Science and Business Media LLC

Subject

Radiology Nuclear Medicine and imaging

Link

http://link.springer.com/content/pdf/10.1007/s11604-012-0088-1.pdf

Reference27 articles.

1. Llovet JM, Burroughs A, Bruix J. Hepatocellular carcinoma. Lancet. 2003;362:1907–17.

2. Cammà C, Schepis F, Orlando A, Albanese M, Shahied L, Trevisani F, et al. Transarterial chemoembolization for unresectable hepatocellular carcinoma: meta-analysis of randomized controlled trials. Radiology. 2002;224:47–54.

3. Llovet JM, Bruix J. Systematic review of randomized trials for unresectable hepatocellular carcinoma: chemoembolization improves survival. Hepatology. 2003;37:429–42.

4. Llovet JM, Real MI, Montaña X, Planas R, Coll S, Aponte J, et al. Arterial embolisation or chemoembolisation versus symptomatic treatment in patients with unresectable hepatocellular carcinoma: a randomized controlled trial. Lancet. 2002;359:1734–9.

5. Lo CM, Ngan H, Tso WK, Liu CL, Lam CM, Poon RT, et al. Randomized controlled trial of transarterial lipiodol chemoembolization for unresectable hepatocellular carcinoma. Hepatology. 2002;35:1164–71.

Cited by 68 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. No lipiodol, no beads—another transcatheter arterial chemoembolization (TACE) with fine cisplatin powder and porous gelatin particles for TACE‐naïve, multifocal, up‐to‐seven out hepatocellular carcinoma;Cancer Medicine;2024-07

2. Retrospective Analysis of Aberrant Hepatic Artery in 1250 Patients with Hepatocellular Carcinoma Undergoing Transarterial Chemoembolization;Annali Italiani di Chirurgia;2024-06-20

3. Comparing Safety and Efficacy of TACE + Apatinib in Combination with a PD-1 Inhibitor versus a Non-triple Therapy for Treating Advanced Primary Hepatocellular Carcinoma: A Systematic Review and Meta-analysis;Journal of Gastrointestinal and Liver Diseases;2024-03-30

4. Preoperative transarterial chemoembolization does not improve the outcomes of resectable hepatocellular carcinoma: A propensity score-matched study;International Journal of Gastrointestinal Intervention;2023-10-31

5. Transarterial chemoembolization for hepatocellular carcinoma: 2023 expert consensus-based practical recommendations of the Korean Liver Cancer Association;Journal of Liver Cancer;2023-09-30